Medication info
New Simvastatin Tablet (Simvastatin)

New Simvastatin Tablet (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Ahn-Guk New Pharm Co., Ltd.
Appearance
Brownish-yellow oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201800820 · Approved 2018.02.14

Summary

Main use
Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular diseases (including myocardial infarction)
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in hypercholesterolemic patients with coronary heart disease and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. Administration of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL cholesterol level before treatment, treatment goals, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose accordingly. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine is restricted to patients who have taken 80 mg of this medicine for 12 months or more without evidence of muscle toxicity, particularly during the first year of treatment (see ‘Warnings’). 2) For recommended doses in patients receiving this medicine concomitantly with fibrates (except gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), refer to the information below (see 6. Drug Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. This medicine should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. (2) In older adults, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or concomitantly with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (except gemfibrozil (see 2. Patients in Whom the Medicine Must Not Be Administered under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Administration to patients with renal impairment As this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg daily and monitor carefully.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose as appropriate for each patient according to the recommended treatment goals. Dose adjustments should be made at intervals of 4 weeks or more.

Ingredients

Manufacturer
Ahn-Guk New Pharm Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular diseases (including myocardial infarction)

  • Coronary artery heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases and improve blood lipid levels in patients with hyperlipidemia and familial hypercholesterolemia. It particularly helps to reduce the nonfatal risks of cardiac death, myocardial infarction, and stroke in high-risk adult patients associated with coronary artery heart disease, diabetes, peripheral vascular disease, and stroke. It also lowers total cholesterol and LDL cholesterol while increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia, serving as an adjunct to dietary therapy. It effectively controls blood lipid levels in pediatric patients with heterozygous familial hypercholesterolemia aged 10 to 17 years. Overall, this medication is utilized to improve the risk of cardiovascular diseases and treat dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in hypercholesterolemic patients with coronary heart disease and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. Administration of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose as appropriate according to the initial LDL cholesterol level before treatment, treatment goals, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose accordingly. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine is restricted to patients who have taken 80 mg of this medicine for 12 months or more without evidence of muscle toxicity, particularly during the first year of treatment (see ‘Warnings’). 2) For recommended doses in patients receiving this medicine concomitantly with fibrates (except gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), refer to the information below (see 6. Drug Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia In controlled clinical trials, patients with homozygous familial hypercholesterolemia received 40 mg of this medicine once daily in the evening. This medicine should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. (2) In older adults, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg daily. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg daily. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or concomitantly with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (except gemfibrozil (see 2. Patients in Whom the Medicine Must Not Be Administered under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg daily. (6) Administration to patients with renal impairment As this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, initiate treatment at 5 mg daily and monitor carefully.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose as appropriate for each patient according to the recommended treatment goals. Dose adjustments should be made at intervals of 4 weeks or more.

Precautions

This medication can cause serious muscle-related diseases, such as myopathy and rhabdomyolysis. The risk is particularly higher when taking high doses, necessitating caution. Patients who are allergic to this medication, have liver diseases, are pregnant or breastfeeding, and those taking certain medications should not use this medication. Patients with liver and kidney problems, hypothyroidism, a family history of muscle diseases, elderly patients, and women should use this medication with extra caution. While taking this medication, if symptoms such as muscle pain or weakness occur, please inform your doctor immediately, and if these symptoms worsen, discontinue the medication. This medication may affect liver function, requiring regular liver function tests. If abnormalities are found, appropriate measures should be taken. Additionally, this medication may interact with several other medications; thus, if you are taking other medications, you must inform your doctor or pharmacist. Pregnant women or those who may become pregnant should not take this medication, and if pregnancy is confirmed while taking it, they should discontinue it immediately. Breastfeeding women must also discontinue breastfeeding if they take this medication, and special care is needed when prescribing it to children and the elderly. In case of overdose, seek medical attention immediately for appropriate treatment, and store this medication out of the reach of children. During the course of taking this medication, muscle pain, liver function abnormalities, allergic reactions, and neurological symptoms may occur; if any abnormal symptoms arise, contact medical personnel immediately.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 80 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • ocular motility disorder
  • facial paresis
  • tremor
  • sensory abnormalities
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • thrombocytopenia
  • lupus erythematosus-like syndrome
  • vasculitis
  • dermatomyositis
  • purpura
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • pancreatitis
  • fatal liver failure
  • cholestatic jaundice
  • liver fat changes
  • liver cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • limb sensory numbness
  • paresthesia
  • cold sensation
  • muscle weakness
  • erectile dysfunction
  • urinary tract infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

Brownish-yellow oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.